Clinical trialNCT01091246CompletedPhase 3Interventional

A Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in Children

SponsorMedImmune LLCEnrollment2,312Healthy or Stable Chronic Illness

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary objective of this study is to demonstrate the immunologic noninferiority of Q/LAIV to FluMist in children 2 to 17 years of age.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Judith Falloon, M.D.
MedImmune LLC
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

110 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Birmingham, Alabama, United States
Research Site
Mobile, Alabama, United States
Research Site
Tucson, Arizona, United States
Research Site
Benton, Arkansas, United States
Research Site
Bentonville, Arkansas, United States
Research Site
Fayetteville, Arkansas, United States
Research Site
Jonesboro, Arkansas, United States
Research Site
Little Rock, Arkansas, United States
Research Site
Anaheim, California, United States
Research Site
Fountain Valley, California, United States
Research Site
Fresno, California, United States
Research Site
Long Beach, California, United States
Research Site
Paramount, California, United States
Research Site
Sacramento, California, United States
Research Site
San Francisco, California, United States
Research Site
West Covina, California, United States
Research Site
Wilmington, Delaware, United States
Research Site
Boca Raton, Florida, United States
Research Site
Jacksonville, Florida, United States
Research Site
Miami, Florida, United States
Research Site
Miami, Florida, United States
Research Site
Ponte Vedra, Florida, United States
Research Site
South Miami, Florida, United States
Research Site
St. Petersburg, Florida, United States
Research Site
West Palm Beach, Florida, United States
Research Site
Dalton, Georgia, United States
Research Site
Marietta, Georgia, United States
Research Site
Woodstock, Georgia, United States
Research Site
Chicago, Illinois, United States
Research Site
DeKalb, Illinois, United States
Research Site
Newton, Kansas, United States
Research Site
Overland Park, Kansas, United States
Research Site
Wichita, Kansas, United States
Research Site
Bardstown, Kentucky, United States
Research Site
Lexington, Kentucky, United States
Research Site
Metairie, Louisiana, United States
Research Site
Kalamazoo, Michigan, United States
Research Site
Niles, Michigan, United States
Research Site
Stevensville, Michigan, United States
Research Site
Plymouth, Minnesota, United States

70 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

FluMist/B/VictoriaFluMist/B/YamagataGlutamine

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Mar 2010
Primary completion: 31 Jul 2010
Completion: 31 Dec 2010
Last update posted: 26 Sept 2011
Registered enrollment: 2,312
Registry id: NCT01091246

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.